'Myocardial depression' or' septic cardiomyopathy'?

Yearbook of Intensive Care and Emergency Medicine 2009

Volumn , Issue , 2007, Pages 183-194

  Werdan, K ^a   Oelke, A ^a   Muller Werdan U ^a  

^a Martin Luther University Hale Wittenberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892033022     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-92278-2_18     Document Type: Chapter

References (41)

1. Parrillo JE (1989) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40: 469-485
2. Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the Heart: Molecular Mechanisms of Septic Cardiomyopathy. Landes Bioscience, Austin
3. Schmidt H, Müller-Werdan U, Werdan K (2008) The consequences of cardiac autonomic dysfunction in multiple organ dysfunction syndrome. In: Vincent JL (ed) 2008 Yearbook of Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 55-64
4. Pilz G, McGinn P, Boekstegers P, Kääb S, Weidenhöfer S, Werdan K (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-pseudomonas sepsis. Circ Shock 42: 174-182
5. Levy RJ, Piel DA, Acton PD, et al (2005) Evidence of myocardial hibernation in the septic heart. Crit Care Med 33: 2752-2756
6. Elliott P, Andersson B, Arbustini E, et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group On Myocardial and Pericardial Diseases. Eur Heart J 29: 270-276
7. Spies C, Haude V, Fitzner R, et al (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113: 1055-1063
8. Wu AHB (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27: 959-961
9. Brueckmann M, Huhle G, Lang S, et al (2005) Prognostic value of plasma N-Terminal probrain natriuretic peptide in patients with severe sepsis. Circulation 112: 527-534
10. Charpentier J, Luyt C-E, Fulla Y, et al (2004) Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32: 660-665
11. Witthaut R, Busch C, Fraunberger P, et al K (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsisassociated left ventricular dysfunction. Intensive Care Med 29: 1696-1702
12. McLean AS, Huang SJ (2006) Intensive care echocardiography. In: Vincent JL (ed) 2006 Yearbook of Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 131-141
13. Cotter G, Moshkovitz Y, Kaluski E, et al (2003) The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Failure 5: 443-451
14. Maeder M, Ammann P, Kiowski W, Rickli H (2005) B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail 7: 1164-1167
15. Müller-Werdan U, Buerke M, Ebelt H (2006) Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol 11: 226-236
16. Levy RJ (2007) Mitochondrial dysfunction, bioenergetic impairment, and metabolic downregulation in sepsis. Shock 28: 24-28
17. Cinel I, Nanda R, Dellinger RP (2008) Cardiac dysfunction in septic shock. In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine. Springer Heidelberg, pp 43-54
18. Zorn-Pauly K, Pelzmann B, Lang P, et al (2007) Endotoxin impairs the human pacemaker current If. Shock 28: 655-661
19. Dhainaut JF, Hughebaert M-F, Monsallier JF, et al (1987) Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75: 533-541
20. Dhainaut J-F, Pinsky MR, Nouria S, Slomka F, Brunet F (1997) Right ventricular function in human sepsis - A thermodilution study. Chest 112: 1043-1049.
21. Varriale P, Ramaprasad S (1995) Septic cardiomyopathy as a cause of long QT syndrome. J Electrocardiology 28: 327-329
22. Prondzinsky R, Stache N, Witthaut R, et al (1997) Multiorgan-failure (MOF) with and without sepsis: differences in incidence and pattern of detected arrhythmias. Crit Care 1 (Suppl 1): P30
23. Knotzer H, Mayr A, Ulmer H, et al (2000) Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med 26: 908-914
24. Müller-Werdan U, Engelmann H, Werdan K (1998) Cardiodepression by tumor necrosis factor α. Eur Cytokine Netw 9: 689-691
25. Müller-Werdan U, Werdan K (2000) Immune modulation by catecholamines - a potential mechanism of cytokine release in heart failure? Herz 25: 271-273
26. Müller-Werdan U, Jacoby J, Loppnow H, et al (1999) Noradrenaline stimulates cardiomyocytes to produce interleukin-6, indicative of a proinflammatory action, which is suppressed by carvedilol. Eur Heart J 20 (Suppl):P1721 (abst)
27. Godin P J, Buchman T G (1996) Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107-1116
28. Schmidt H, Muller-Werdan U, Hoffmann T, et al (2005) Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 33: 1994-2002
29. Tracey K J (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117: 289-296
30. Godin P J, Fleisher L A, Eidsath A, et al (1996) Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med 24: 1117-1124.
31. Baruscotti M, Bucchi A, & Difrancesco D (2005) Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol Ther 107: 59-79
32. Ludwig A, Zong X, Hofmann F, & Biel M (1999) Structure and function of cardiac pacemaker channels. Cell Physiol Biochem 9: 179-186
33. Schmidt H, Saworski J, Werdan K, Muller-Werdan U (2007) Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin. J Endotoxin Res 13: 339-342
34. Kurata Y, Hisatome I, Imanishi S, Shibamoto T (2002) Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell. Am J Physiol Heart Circ Physiol 283: H2074-2101
35. Sakr Y, Reinhart K, Vincent JL, et al (2006) Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34: 589-597
36. Cunha-Goncalves D, Perez-de-Sa V, Dahm P, Grins E, Thörne J, Blomquist S (2007) Cardiovascular effects of levosimendan in the early stages of endotoxemia. Shock 28: 71-77
37. Takeuchi K, del Nido PJ, Ibrahim AE, et al (1999) Vesnarinone and amrinone reduce the systemic inflammatory response syndrome. J Thorac Cardiovasc Surg 117: 375-381
38. Wagner DR, McTiernan C, Sanders VJ, Feldman AM (1998) Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-α in the failing human heart. Circulation 97: 521-524
39. Suzuki T, Morisaki H, Serita R, et al (2005) Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 33: 2294-2301
40. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL (2002) Microvascular blood flow is altered in sepsis. Am J Respir Crit Care Med 166: 98-104
41. Elebute EA, Stoner HB (1983) The grading of sepsis. Br J Surg 70: 29-31